Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Patient Related Outcome Measures|November 2, 2017
A pilot study of subjective well-being in colorectal cancer patients and their caregiversJanet Graham, Pavlina Spiliopoulou, Rob Arbuckle, et al.
Chemical Communications (Cambridge, England)|September 7, 2023
Quantum shells versus quantum dots: suppressing Auger recombination in colloidal semiconductorsJacob Beavon, Jiamin Huang, Dulanjan Harankahage, et al.
Nano Letters|May 26, 2021
Photoinduced Rotation of Colloidal Semiconductor Nanocrystals in an Electric FieldDmitry Porotnikov, Dulanjan Harankahage, Cole Ellison, et al.
Cancer Research|November 19, 2004
Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cellsWeiguang Wang, James Cassidy, Vincent O'Brien, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2006
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networksWeiguang Wang, Howard L McLeod, James Cassidy, et al.
Nano Letters|July 3, 2025
Evaluating Brightness and Stability of Cathodoluminescence from Colloidal Semiconductor NanocrystalsBenjamin T Diroll, Robert Sevik, Muchuan Hua, et al.
Investigational New Drugs|May 19, 2011
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I studyJens Samol, Malcolm Ranson, Edwina Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumorsGernot Beutel, Hilary Glen, Patrick Schöffski, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2008
Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)Janet S Graham, Ruth Plummer, Candice McCoy, et al.
Oncology Reports|February 12, 2002
Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasisSharon Marsh, Judith A McKay, Stephanie Curran, et al.
Pageof 6